Eventide Healthcare & Life Sciences Fd Cl I (ETIHX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.27: the stock has moved about 27% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerEventide Healthcare & Life Sciences Fd Cl I (ETIHX) trades at $52.37. Eventide Healthcare & Life Sciences Fd Cl I is a mutual fund focused on long-term capital appreciation through investments in the healthcare and life sciences sectors. Sector: Financials.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for ETIHX: ETIHX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Eventide Healthcare & Life Sciences Fd Cl I (ETIHX) Financial Services Profile
Eventide Healthcare & Life Sciences Fd Cl I is a mutual fund specializing in equity and equity-related securities within the healthcare and life sciences sectors. The fund invests across market capitalizations and geographies, including ADRs, aiming for long-term capital appreciation. It operates within the competitive asset management industry.
What Is the Investment Thesis for ETIHX?
Eventide Healthcare & Life Sciences Fd Cl I presents an investment opportunity within the growing healthcare and life sciences sectors. The fund's focus on long-term capital appreciation aligns with the potential for innovation and growth within these industries. A key value driver is the fund's ability to invest across market capitalizations and geographies, providing diversification and access to a broader range of investment opportunities. The fund's investment in ADRs allows it to tap into international markets. Potential risks include market volatility and sector-specific risks associated with the healthcare and life sciences industries. The fund's performance is also dependent on the expertise of its investment management team and their ability to identify and capitalize on investment opportunities. The fund's beta of 1.27 suggests higher volatility compared to the market.
Based on FMP financials and quantitative analysis
ETIHX Key Highlights
The fund invests at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences sectors.
- The fund can invest without limitation in securities of companies domiciled outside the United States, either directly or through American Depositary Receipts (ADRs).
- The fund may invest in securities of companies of any market capitalization.
- The fund's objective is to provide long-term capital appreciation.
- The fund has a market capitalization of $1.22 billion.
Who Are ETIHX's Competitors?
ETIHX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BAUAX Brown Advisory Small-Cap Fundamental Value Fund Advisor Shs | $29.76 | -1.36% | $1.13B | — |
| CVMAX Calvert Emerging Markets Equity Fund Class A | $29.12 | -1.49% | $1.80B | — |
| HAVLX Harbor Large Cap Value Fund Institutional Class | $20.13 | +0.65% | $949M | — |
| JOEAX JOHCM Emerging Markets Opportunities Fund - Investor Shares | $17.75 | -0.06% | $1.72B | — |
| NEFJX Natixis Funds Trust I Vaughan Nelson Small Cap Value Fund | $21.45 | -1.65% | $1.44B | — |
| BLK BlackRock, Inc. | $1069.63 | -0.91% | $167B | 52 5-pillar |
| BX Blackstone Inc. | $111.80 | -1.38% | $135B | 69 5-pillar |
| APOS Apollo Global Management, Inc. | $25.43 | -0.66% | $74.6B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ETIHX's Key Strengths?
Specialized focus on the healthcare and life sciences sectors.
- Ability to invest across market capitalizations and geographies.
- Access to international markets through ADRs.
- Objective of long-term capital appreciation.
What Are ETIHX's Weaknesses?
Sector-specific focus may limit diversification.
- Performance is dependent on the healthcare and life sciences sectors.
- Subject to market volatility and sector-specific risks.
- No dividend yield.
What Are the Key Risks for ETIHX?
Market volatility and economic downturns.
- Sector-specific risks associated with healthcare and life sciences.
- Regulatory changes and healthcare policy risks.
- Competition from other asset management firms.
- Drug development and clinical trial risks.
What Are ETIHX's Competitive Advantages?
- Specialized focus on the healthcare and life sciences sectors.
- Ability to invest across market capitalizations and geographies.
- Access to international markets through ADRs.
What Does ETIHX Do?
Eventide Healthcare & Life Sciences Fd Cl I is a mutual fund with the stated objective of achieving long-term capital appreciation. The fund focuses its investments primarily within the healthcare and life sciences sectors. Under normal market conditions, the fund allocates at least 80% of its net assets, plus borrowings for investment purposes, into equity and equity-related securities of companies operating in these sectors. These securities include common stock, options, preferred stock, and convertible debt. The fund's investment strategy is not limited by geography, as it may invest in securities of companies domiciled outside the United States, either directly or through American Depositary Receipts (ADRs). This global approach allows the fund to tap into growth opportunities in the international healthcare and life sciences markets. Furthermore, the fund is not restricted by market capitalization, enabling it to invest in companies of all sizes, from small-cap to large-cap. Eventide Healthcare & Life Sciences Fd Cl I operates within the asset management industry, offering investors a specialized investment vehicle focused on the healthcare and life sciences sectors. The fund competes with other mutual funds and investment firms that offer similar sector-specific investment products.
What Products and Services Does ETIHX Offer?
- Invests in equity and equity-related securities.
- Focuses on companies in the healthcare and life sciences sectors.
- Invests in common stock, options, preferred stock, and convertible debt.
- Invests in companies of any market capitalization.
- May invest in securities of companies domiciled outside the United States.
- May invest through American Depositary Receipts (ADRs).
How Does ETIHX Make Money?
- Generates revenue through investment management fees.
- Aims to provide long-term capital appreciation for investors.
- Allocates capital to companies in the healthcare and life sciences sectors.
What Industry Does ETIHX Operate In?
Eventide Healthcare & Life Sciences Fd Cl I operates within the asset management industry, specifically focusing on the healthcare and life sciences sectors. The asset management industry is characterized by intense competition, with numerous firms offering a wide range of investment products and strategies. The healthcare and life sciences sectors are driven by factors such as an aging global population, advancements in medical technology, and increasing healthcare spending. These sectors are also subject to regulatory scrutiny and potential risks associated with drug development and clinical trials. The fund's performance is influenced by the overall market trends and the performance of the healthcare and life sciences sectors.
Who Are ETIHX's Key Customers?
- Individual investors seeking exposure to the healthcare and life sciences sectors.
- Institutional investors looking for long-term capital appreciation.
- Retirement savers seeking diversified investment options.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 43 snapshots
| 2026-08-23 | 47 |
| 2026-08-31 | 47 |
| 2026-09-08 | 47 |
| 2026-09-16 | 47 |
| 2026-09-24 | 47 |
| 2026-10-04 | 47 |
| 2026-10-06 | 47 |
What changed?
The score has stayed at 47.
Over the same 30 days the stock moved -10.3%.
ETIHX Financials
Bull Case vs Bear Case
Bull Case
- Specialized focus on the healthcare and life sciences sectors.
- Ability to invest across market capitalizations and geographies.
- Access to international markets through ADRs.
- Objective of long-term capital appreciation.
Bear Case
- Sector-specific focus may limit diversification.
- Performance is dependent on the healthcare and life sciences sectors.
- Subject to market volatility and sector-specific risks.
- No dividend yield.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ETIHX Latest News
No recent news available for ETIHX.
ETIHX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ETIHX.
Price Targets
Wall Street price target analysis for ETIHX.
ETIHX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ETIHX; grades run from A+ (80-100) to F (below 30).
ETIHX Financials Stock FAQ
What are the main risks for ETIHX?
The main risks for ETIHX include market volatility, sector-specific risks associated with the healthcare and life sciences industries, regulatory changes, and competition from other asset management firms. The fund's performance is dependent on the overall market conditions and the performance of the healthcare and life sciences sectors. Regulatory changes and healthcare policy reforms can also impact the fund's investments.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The information provided is based on the available data and may be subject to change.